269 related articles for article (PubMed ID: 34250789)
1. Cochlear implantation after radiosurgery for vestibular schwannoma.
Patel NS; Carlson ML; Link MJ; Neff BA; Van Gompel JJ; Driscoll CLW
J Neurosurg; 2021 Jul; 135(1):126-135. PubMed ID: 34250789
[TBL] [Abstract][Full Text] [Related]
2. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
3. Cochlear Implant Outcomes between Patients with Sporadic and Neurofibromatosis Type 2-Associated Vestibular Schwannoma.
Dornhoffer JR; Haller T; Lohse CM; Driscoll CLW; Neff BA; Saoji A; Link MJ; Carlson ML
Otol Neurotol; 2023 Sep; 44(8):791-797. PubMed ID: 37464449
[TBL] [Abstract][Full Text] [Related]
4. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.
Mallory GW; Pollock BE; Foote RL; Carlson ML; Driscoll CL; Link MJ
Neurosurgery; 2014 Mar; 74(3):292-300; discussion 300-1. PubMed ID: 24335819
[TBL] [Abstract][Full Text] [Related]
6. Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas.
Urban MJ; Moore DM; Kwarta K; Leonetti J; Rajasekhar R; Gluth MB; Wiet RM
Ann Otol Rhinol Laryngol; 2020 Dec; 129(12):1229-1238. PubMed ID: 32551844
[TBL] [Abstract][Full Text] [Related]
7. Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2.
Tan H; Jia H; Li Y; Zhang Z; Zhu W; Cai Y; Wang Z; Wu H
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2667-2674. PubMed ID: 30229456
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Cochlear Implantation in Neurofibromatosis Type 2 Related Hearing Loss.
Sobczak G; Marchant W; Misurelli S; Pyle GM; Gubbels S; Roche J
Ann Otol Rhinol Laryngol; 2023 Mar; 132(3):284-293. PubMed ID: 35450430
[TBL] [Abstract][Full Text] [Related]
9. Comparing Speech Recognition Outcomes Between Cochlear Implants and Auditory Brainstem Implants in Patients With NF2-Related Schwannomatosis.
Dornhoffer JR; Plitt AR; Lohse CM; Driscoll CLW; Neff BA; Saoji AA; Van Gompel JJ; Link MJ; Carlson ML
Otol Neurotol; 2024 Jan; 45(1):29-35. PubMed ID: 37875011
[TBL] [Abstract][Full Text] [Related]
10. Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2.
Lloyd SK; Glynn FJ; Rutherford SA; King AT; Mawman DJ; O'Driscoll MP; Evans DG; Ramsden RT; Freeman SR
Otol Neurotol; 2014 Jan; 35(1):43-51. PubMed ID: 24335931
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
[TBL] [Abstract][Full Text] [Related]
12. Management of sporadic vestibular schwannoma with contralateral nonserviceable hearing.
Jia H; Nguyen Y; De Seta D; Hochet B; Smail M; Bernardeschi D; Wu H; Mosnier I; Kalamarides M; Sterkers O
Laryngoscope; 2020 Jun; 130(6):E407-E415. PubMed ID: 31643090
[TBL] [Abstract][Full Text] [Related]
13. Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions.
Jacob JT; Carlson ML; Schiefer TK; Pollock BE; Driscoll CL; Link MJ
Neurosurgery; 2014 May; 74(5):466-74; discussion 474. PubMed ID: 24476904
[TBL] [Abstract][Full Text] [Related]
14. Cochlear implantation for hearing rehabilitation in single-sided deafness after translabyrinthine vestibular schwannoma surgery.
Hassepass F; Arndt S; Aschendorff A; Laszig R; Wesarg T
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2373-83. PubMed ID: 26498948
[TBL] [Abstract][Full Text] [Related]
15. Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants.
Roehm PC; Mallen-St Clair J; Jethanamest D; Golfinos JG; Shapiro W; Waltzman S; Roland JT
J Neurosurg; 2011 Oct; 115(4):827-34. PubMed ID: 21761973
[TBL] [Abstract][Full Text] [Related]
16. Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients.
Boari N; Bailo M; Gagliardi F; Franzin A; Gemma M; del Vecchio A; Bolognesi A; Picozzi P; Mortini P
J Neurosurg; 2014 Dec; 121 Suppl():123-42. PubMed ID: 25434946
[TBL] [Abstract][Full Text] [Related]
17. Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.
Harris F; Tysome JR; Donnelly N; Durie-Gair J; Crundwell G; Tam YC; Knight RD; Vanat ZH; Folland N; Axon P
Cochlear Implants Int; 2017 May; 18(3):171-179. PubMed ID: 28335700
[TBL] [Abstract][Full Text] [Related]
18. Ipsilateral cochlear implantation in patients with sporadic vestibular schwannoma in the only or best hearing ear and in patients with NF2.
Lassaletta L; Aristegui M; Medina M; Aranguez G; Pérez-Mora RM; Falcioni M; Gavilán J; Piazza P; Sanna M
Eur Arch Otorhinolaryngol; 2016 Jan; 273(1):27-35. PubMed ID: 25537817
[TBL] [Abstract][Full Text] [Related]
19. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.
Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP
Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of cochlear implantation in patients with neurofibromatosis type 2.
North HJ; Mawman D; O'Driscoll M; Freeman SR; Rutherford SA; King AT; Hammerbeck-Ward C; Evans DG; Lloyd SK
Cochlear Implants Int; 2016 Jul; 17(4):172-177. PubMed ID: 27691934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
